Randomized Controlled Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer

Trial Profile

Randomized Controlled Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer

Recruiting
Phase of Trial: Phase II

Latest Information Update: 09 Nov 2017

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary)
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Acronyms MATEO
  • Most Recent Events

    • 11 Oct 2016 Trial design presented at the 41st European Society for Medical Oncology Congress.
    • 17 Dec 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 16 Aug 2014 New source identified and integrated. (European Clinical Trials Database)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top